Print Share Email Twitter Facebook Linkedin Reddit Get Citation Citation Disclaimer: These citations have been automatically generated based on the information we have and it may not be 100% accurate. Please consult the latest official manual style if you have any questions regarding the format accuracy. AMA Citation Havrda D. Havrda D Havrda, Dawn. The Effect of a New GLP-1 Agonist, Efpeglenatide, on Cardiovascular and Renal Outcomes in Diabetes. Topics in Evidence-Based Pharmacy Practice, 7 April 2022. McGraw Hill, 2022. AccessPharmacy. https://accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=582750§ionid=266511168APA Citation Havrda D. Havrda D Havrda, Dawn. (2022). The effect of a new glp-1 agonist, efpeglenatide, on cardiovascular and renal outcomes in diabetes. Linn WD. Linn W.D. Linn, William D. Topics in evidence-based pharmacy practice. McGraw Hill. https://accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=582750§ionid=266511168.MLA Citation Havrda D. Havrda D Havrda, Dawn. "The Effect of a New GLP-1 Agonist, Efpeglenatide, on Cardiovascular and Renal Outcomes in Diabetes." Topics in Evidence-Based Pharmacy Practice Linn WD. Linn W.D. Linn, William D. McGraw Hill, 2022, https://accesspharmacy.mhmedical.com/updatesContent.aspx?gbosid=582750§ionid=266511168. Download citation file: RIS (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley © Copyright Tools Annotate Clip Autosuggest Results Your MyAccess profile is currently affiliated with '[InstitutionA]' and is in the process of switching affiliations to '[InstitutionB]'. Please click ‘Continue’ to continue the affiliation switch, otherwise click ‘Cancel’ to cancel signing in. Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Username Error: Please enter User Name Password Error: Please enter Password Forgot Username? Forgot Password? Sign in via OpenAthens Sign in via Shibboleth